Invivo Corporation: FDA filings under this applicant name
FDA lists 39 510(k) clearances under 3 spellings of the applicant name “Invivo Corporation” (first 2005, latest 2021), across 5 product codes in 3 review panels. Median 510(k) review time under this name: 41 days. Since 2017 the median was 26 days, against 143 days for all cleared 510(k)s in the same product codes. Related companies, subsidiaries and acquired businesses that file under other applicant names are counted on their own pages, not here.
Caduvo groups this applicant name under Philips, based on public ownership records.
510(k) clearances per year
| Year | Clearances | Median review days |
|---|---|---|
| 2012 | 4 | 47 |
| 2013 | 3 | 53 |
| 2014 | 1 | 118 |
| 2015 | 2 | 76 |
| 2016 | 2 | 42 |
| 2017 | 0 | — |
| 2018 | 1 | 31 |
| 2019 | 2 | 39 |
| 2020 | 0 | — |
| 2021 | 3 | 22 |
| 2022 | 0 | — |
| 2023 | 0 | — |
| 2024 | 0 | — |
| 2025 | 0 | — |
| 2026 | 0 | — |
Review time against the same product codes
Since 2017, 510(k)s cleared under the name Invivo Corporation took a median 26 days from FDA receipt to decision. All cleared 510(k)s in the same product codes over the same years took a median 143 days.
Top product codes
| Product code | Device | Submissions | 510(k) clearances |
|---|---|---|---|
| MOS | Coil, Magnetic Resonance, Specialty | 21 | 21 |
| MWI | Monitor, Physiological, Patient (Without Arrhythmia Detection Or Alarms) | 8 | 8 |
| LLZ | System, Image Processing, Radiological | 7 | 7 |
| MHX | Monitor, Physiological, Patient(With Arrhythmia Detection Or Alarms) | 2 | 2 |
| DQA | Oximeter | 1 | 1 |
Review panels
- Radiology (28)
- Cardiovascular (10)
- Anesthesiology (1)
Most recent Invivo Corporation 510(k) clearances
| 510(k) | Device | Product code | Decision date | Review days |
|---|---|---|---|---|
| K213766 | dS FootAnkle 16Ch Coils for 1.5T and 3.0T, dS HiRes HandWrist 16Ch Coils for 1.5T and 3.0T, ds Small Extremity 16Ch Coils for 1.5T and 3.0T | MOS | 2021-12-23 | 22 |
| K212227 | Philips MR Patient Care Portal | MWI | 2021-09-30 | 76 |
| K212175 | DynaCAD | LLZ | 2021-08-02 | 21 |
| K193403 | UroNav System | LLZ | 2019-12-27 | 21 |
| K192200 | DynaCAD | LLZ | 2019-10-09 | 57 |
| K182561 | UroNav (Version 3.0) | LLZ | 2018-10-19 | 31 |
| K162177 | dS FootAnkle I6CH 1.5T Coil | MOS | 2016-09-14 | 41 |
| K162001 | 1.5T and 3.0T 16 CH GE Shoulder Coils | MOS | 2016-08-31 | 42 |
| K152330 | Expression MR400 MRI Patient Monitoring System | MWI | 2015-12-23 | 127 |
| K153073 | UroNav (Version 2.0) | LLZ | 2015-11-16 | 25 |
29 earlier clearances. See the full list in Caduvo.
Recalls
22 product recalls in 22 recall events; 0 initiated in the last five years. Most recent: 2020-09-14.
12 product recalls in 6 recall events filed under other recalling-firm names cite a 510(k) or PMA held under this applicant name; 6 initiated in the last five years. Most often: Philips North America Llc (6), Philips North America, LLC (5), Philips Electronics North America Corporation (1).
These recall records list the clearance number, so the device was cleared under this name. The recalling firm may be the same company under another spelling, a company that acquired the product line, a relabeler or a contract manufacturer. They are not added to the count above.
Recalling firms are matched to this applicant name by name only (same normalization), so related entities that recall under another name are not counted. A recall count says nothing about how safe one company's devices are compared with another's.
Parent company SEC filings
KONINKLIJKE PHILIPS NV (PHG, RYLPF): EDGAR filings, CIK 313216. Caduvo groups Invivo Corporation under Philips; the parent's SEC registrant is entered by hand for the group, not matched by name.
Related HCPCS codes
HCPCS Level II codes whose descriptors match the device names of the product codes filed under Invivo Corporation (a text match, not an official crosswalk):
- C8900 — Magnetic resonance angiography with contrast, abdomen (via MOS)
- C8901 — Magnetic resonance angiography without contrast, abdomen (via MOS)
- C8918 — Magnetic resonance angiography with contrast, pelvis (via MOS)
- C8919 — Magnetic resonance angiography without contrast, pelvis (via MOS)
- C8902 — Magnetic resonance angiography without contrast followed by with contrast, abdomen (via MOS)
FDA spellings included
FDA records this applicant under 3 spellings (case, punctuation and legal-suffix variants of one name); this page adds them up. Filings per spelling:
- Invivo Corporation (29)
- Invivo (6)
- Invivo Corp. (4)
Other FDA applicant names starting with the same word
FDA records these as separate applicants. Some may belong to the same corporate group and some may not; their filings are not included in the counts above.
- Invivo Research, Inc. (14 510(k)s)
- Invivo Corporation (Business Trade Name: Philips) (6 510(k)s)
- Invivo Research Labs, Inc. (5 510(k)s)
- Invivo Therapeutics Corporation (1 510(k)s)
Frequently asked questions
How many FDA 510(k) clearances are listed under Invivo Corporation?
FDA lists 39 510(k) clearances under 3 spellings of the applicant name “Invivo Corporation” (first 2005, latest 2021), across 5 product codes in 3 review panels. Filings under other applicant names, such as subsidiaries, are not included.
How long has FDA taken to clear 510(k)s filed by Invivo Corporation?
The median time from FDA receipt to decision across 510(k)s cleared under the name Invivo Corporation is 41 days. Since 2017: 26 days, versus 143 days for all cleared 510(k)s in the same product codes.
Which FDA product codes appear under Invivo Corporation?
The most frequent FDA product codes under this applicant name are MOS (Coil, Magnetic Resonance, Specialty, 21); MWI (Monitor, Physiological, Patient (Without Arrhythmia Detection Or Alarms), 8); LLZ (System, Image Processing, Radiological, 7).
Next steps
- See all 39 Invivo Corporation clearances with predicates and recalls
- Run predicate analysis for product code MOS, Invivo Corporation's most frequent
Compiled by Caduvo from public U.S. government records. Counts cover filings under the applicant names shown on this page only. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA or any other agency, or by the companies named. Not regulatory advice. Report an error in this data. Data and corrections policy.